I could hardly believe that today someone has already bought a large part of my $DE0006288632 at one of the highest prices in the history of this global stock.

With yesterday's sale at €80 per share (minus expenses and brokerage), I had probably set a positive price anchor on the over-the-counter share. This morning I decided to offer more of my shares for €75 in order to create a "positive incentive to buy". Just a few hours later, I received the sales email from the OTC trading platform.

I was delighted, as I had bought the shares two years ago for €49.70. With dividends of €1.1 and €1.5 in the last few years, they had already done some good for the portfolio.

With some play money in my pocket again, this time it was time for a less daring bet than yesterday's last two investments.

My choice fell on $CVS (+0,8 %) which was unfortunately close to its high for the day at the time of purchase. Because I am inexperienced and suspected that the upward trend would continue and that I would not be able to get the shares "so cheaply", I bought them for [52.49€]. The shares were thus just below the 15% threshold above the 52-week low. That was my "pain threshold". A bit expensive for this long-term dividend payer, but I am happy to have bought the $DE0006288632 against the $CVS (+0,8 %) to have exchanged them.

The company is active in the healthcare sector and thus fills an open sector gap in the portfolio. In addition, the share of the USA weighting was increased somewhat. Compared to yesterday's purchases, the books also (finally) showed a profit per share.